Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

Press release
Press release |
01 July 2019
Intellectual property and trade
India

MSF update on 26th round of RCEP negotiations in Melbourne, Australia

Vials of Amphotericin B which is used to treat Cryptococcal Meningitis. Photograph by Albert Masias
Press release
Press release |
27 June 2019
HIV/AIDS
Global

Gilead Sciences fails on promise to expand access to lifesaving drug for people living with HIV

6 min
"" Greg Lomas
Press release
Press release |
13 June 2019
HIV/AIDS
South Africa

MSF HIV project in South Africa reaches ambitious global treatment and prevention targets

5 min
Press release |
28 May 2019
Intellectual property and trade Research and development
Global

Member States adopt the resolution on ‘Improving the transparency of markets for medicines, vaccines, and other health products’ at WHA today

2 min
Bonaventure Ndjekpe, 14, is being kept under surveillance at Paoua Hospital, northwestern Central African Republic, supported by MSF. He would have been bitten on the heel by a snake on Christmas Eve, but there is no sign of blood poisoning. 2018. Photograph by Alexis Huguet
Press release
Press release |
23 May 2019
Tropical & neglected diseases
Africa

MSF welcomes release of long-awaited WHO strategy to tackle snakebite

5 min
HIV_Mozambique_pills_AndreFrancois_2012_MSF124560 Photo by Andre Francois
Press release
Press release |
10 May 2019
Research and development

MSF response to World Health Assembly Medicine Price Transparency Resolution negotiations

"" Photograph by Todd Brown
Press release
Press release |
30 April 2019
Intellectual property and trade
IndiaGlobal

U.S. Special 301 Report Undermines Efforts to Lower Medicine Prices Globally

3 min
Press release
Press release |
25 April 2019
Tuberculosis

MSF: Johnson & Johnson should make TB drug available for all at $1/day

8 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury